COMP <GO>
BWAY vs CARL // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
BrainsWay Ltd. (NASDAQ) VS. Carlsmed Inc. (NASDAQ) • 15-METRIC TALLY: BWAY 1
— CARL 1
■ METRIC PARITY
LAST: $11.09 (-2.38%) • MKT CAP: $455.9M
options-implied-move
—
LAST: $15.02 (+0.47%) • MKT CAP: $408.2M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BWAY VS. CARL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BWAY | CARL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 75.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -6.88% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -58.70% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 7.83 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 3/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.6 | 51.5 | -8.90 | CARL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $455.9M | $408.2M | $47.7M | BWAY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BWAY REV | CARL REV | BWAY GROSS % | CARL GROSS % | BWAY FCF | CARL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $50.5M | — | 75.3% | — | -$29.6M |
| FY 2024 | — | $27.2M | — | 73.8% | — | -$25.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BWAY // BETA —
CARL // BETA —